Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Article
Wen, Patrick Y, Chang, Susan M, Lamborn, Kathleen R et al. (2014). Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
. NEURO-ONCOLOGY, 16(4), 567-578. 10.1093/neuonc/not247
Wen, Patrick Y, Chang, Susan M, Lamborn, Kathleen R et al. (2014). Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
. NEURO-ONCOLOGY, 16(4), 567-578. 10.1093/neuonc/not247
Wen, Patrick Y; Chang, Susan M; Lamborn, Kathleen R; Kuhn, John G; Norden, Andrew D; Cloughesy, Timothy F; Robins, H Ian; Lieberman, Frank S; Gilbert, Mark R; Mehta, Minesh P; Drappatz, Jan; Groves, Morris D; Santagata, Sandro; Ligon, Azra H; Yung, WK Alfred; Wright, John J; Dancey, Janet; Aldape, Kenneth D; Prados, Michael D; Ligon, Keith L